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Abstract
Background: Prior studies have independently reported associations between major depressive disorder (MDD), elevated
cortisol concentrations, early adverse events and region-specific decreases in grey matter volume, but the relationships
among these variables are unclear. In the present study, we sought to evaluate the relationships between grey matter
volume, early adverse events and cortisol levels in MDD.
Methods/Results: Grey matter volume was compared between 19 controls and 19 individuals with MDD using voxel-based
morphometry. A history of early adverse events was assessed using the Childhood Trauma Questionnaire. Subjects also
provided salivary cortisol samples. Depressed patients showed decreased grey matter volume in the rostral ACC as
compared to controls. Rostral ACC volume was inversely correlated with both cortisol and early adverse events.
Conclusions: These findings suggest a key relationship between ACC morphology, a history of early adverse events and
circulating cortisol in the pathophysiology of MDD.
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Introduction
Early adverse events are a significant risk factor for the
subsequent development of major depressive disorder (MDD) [1].
It has been theorized that one neurobiological mechanism through
which early adverse events may elevate the risk of developing
depression is by increased activation of the hypothalamic-pituitary-
adrenal (HPA) axis, a key stress-hormone signaling pathway. This
hypothesis is derived from two areas of research. First, both animal
and clinical models suggest that depression is associated with poor
regulation of HPA axis activity, as indicated by elevated cortisol [2],
disruption of circadian HPA rhythms [2,3], and failure to suppress
cortisol levels following administration of the synthetic steroid
dexamethasone [3]. Second, preclinical studies have revealed that
prolonged exposure to glucocorticoids is associated with atrophy of
brain regions involved in the regulation of HPA activity, including
the hippocampus [4] and the medial prefrontal cortex (mPFC) [5].
Stress-related damage to these regulatory regions may precipitate a
cycle of diminished resiliency, in which the system is less able to
regulate HPA activity in response to future stress, resulting in
greater exposure to glucocorticoids.
Considerable prior research has focused on the hippocampus,
given its well-established role in regulating HPA activity, and the
high density of glucocorticoid receptors expressed in this region
[4]. However, more recent work has also emphasized a prominent
role for the mPFC, particularly the anterior cingulate cortex
(ACC). The ACC contains high concentrations of glucocorticoid
receptors (GR) in laminas II, III, and V [6], is vulnerable to the
noxious effects of glucocorticoids [7,8], and may exert inhibitory
control over the HPA axis via GR-mediated negative-feedback
[6,9]. Consistent with these preclinical findings, human neuroim-
aging studies of individuals with MDD have reported volumetric
reductions in the hippocampus [10–15] and the ACC [14,16,17].
Evidence for stress-related structural damage to the anterior
cingulate is particularly relevant for understanding the relationship
between stress and depression, as significant research suggests that
dysregulation within cortico-limbic pathways involving the ACC
may be responsible for impairments in cognition, emotion and
motivation in the disorder [18,19]. Importantly, hypoactivity in
the dorsal subdivision (dACC) [20], and hyperactivity in the rostral
subdivision (rACC) [21] have been demonstrated in MDD, along
with impaired ACC-amygdala connectivity [22].
Methods
Objectives
In the present study, we sought to examine the relationship
between early adverse events, HPA activity and grey matter
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controls, with a particular emphasis on grey matter volume of the
hippocampus and anterior cingulate. By assessing all three
variables within a single sample, the present study is able to
provide a more direct evaluation of the putative neurobiological
mechanisms that are believed to underlie the observed volumetric
decreases in HPA-axis regulatory regions in MDD.
Participants
Nineteen patients with current depression and nineteen healthy
matched control subjects were recruited for this study. All
participants were between 18 and 55 years of age with no significant
history of neurological disease or lifetime history of brain injury,
psychosis, mania, or substance dependence. Additionally, partici-
pants were excluded if they reported substance abuse within the
previous six months. All patients were diagnosed with unipolar
depression and met full criteria for one or more episodes of major
depressive disorder as determined by a Structured Clinical
Interview (SCID) for DSM-IV. Patients were excluded if they met
criteria for specific comorbid Axis I disorders that included alcohol
dependence, obsessive-compulsive disorder, schizophrenia and
other psychotic disorders or bipolar disorder. In addition, all
patients had a score of 16 or higher on the Hamilton Depression
Rating Scale (HDRS) [23]. The presence of Axis-II psychopathol-
ogywasnotassessed.Patientswere antidepressant-freeatthetime of
scanning. Never-depressed control subjects did not meet criteria for
anyAxisImood disordersexceptforonesubject who wasdiagnosed
with mild agoraphobia without panic disorder as determined by the
SCID. All never-depressed control subjects had a score of six or less
on the HDRS. Subjects who met criteria were scheduled for a scan
session within one week of admission to the study.
Ethics Statement
The Vanderbilt University Institutional Review Board approved
the experimental protocol. A complete description of the study was
provided to all participants, and all subjects provided written
informed consent. Subjects were recruited through the Vanderbilt
University Medical Center Outpatient Psychiatry Clinic or
through television advertisements.
Behavioral Measures
To assess a history of early adverse events, participants
completed the Childhood Trauma Questionnaire – Short Form
(CTQ-SF) [24]. The CTQ-SF was developed as a 28-item
questionnaire derived from the original 70-item Childhood
Trauma Questionnaire. The CTQ-SF has 25 clinical questions
and three validity items. The measure has five sub-scales
comprised of five questions each that assess childhood maltreat-
ment in the areas of emotional, physical, or sexual abuse,
emotional neglect and physical neglect. Subjects rate statements
about childhood lifetime experiences on a five-point scale (‘‘never
true’’ to ‘‘very often true’’). Items are generally stated in objective
terms, (e.g., ‘‘When I was growing up, someone touched me in a
sexual way or made me touch them’’), whereas some items require
subjective evaluation (e.g., ‘‘When I was growing up, I believe I
was sexually abused’’) and usually do not specify the relationship of
the perpetrator(s) to the subject. Emotional abuse items are general
(e.g., ‘‘People in my family said hurtful or insulting things to me’’)
but do not investigate the specific verbal content of the abuse.
Reliability and validity of the CTQ, including its stability over
time, convergent and discriminant validity with structured trauma
interviews, and corroboration using independent data, have been
determined. The CTQ-SF has demonstrated high internal
reliability, with (Cronbach’s alphas ranging from .74 to .90) and
good test-retest reliability at three months (r=.80). Scores on each
subscale were calculated by taking the mean value of the five
individual items for each subscale. Scores of patients and controls
subscales were compared using an independent samples t-test,
assuming unequal variance. A Bonferroni correction was applied
to control for multiple comparisons (corrected a=.01).
Salivary Cortisol
Samples of saliva were collected using the Salivette saliva
collection device (Sarstedt, Newton NC). Participants collected
three saliva samples per day for two consecutive days and a sample
on the morning of their MRI scan session on the third day. The
first sample was recorded within 0.5 h after awakening. Two
additional samples were collected at 3:00 PM and 9:00 PM. Using
this method we ensured that we could adequately account for
diurnal variation. Cortisol levels were determined using an enzyme
immunoassay (ALPCO Diagnostics, Salem, NH). For all subse-
quent analyses, the average of all seven cortisol samples was used
unless otherwise specified.
Structural MRI Image Acquisition
Structural MRI scans were acquired on a 3T Philips Intera
Achieva scanner at the Vanderbilt University Institute of Imaging
Sciences (VUIIS). High-resolution structural images were acquired
in the axial plane to facilitate spatial normalization using a 3D IR
Prepped 3DFFE sequence (TR=10.1 ms, TE=4.2 ms,
FOV=24624 cm2, matrix size=2566256, slice thick-
ness=l.2 mm, no gap). Due to scanner error, 3D data were not
available for one subject. For this subject we used a 2D imaging
sequence (TR=450 ms, TE=17 ms, FOV=24624 cm2, matrix
size=2566256, slice thickness=4 mm, no gap). Data for this
subject were re-interpolated into a 3D image matrix (matrix size
2566256). Exclusion of this subject did not alter the results.
Voxel-Based Morphometry
Data were analyzed on a Dell Vostro 200 (Dell Inc, Round Rock,
Tx) running a Linux-based operating system (Ubuntu 7.1). Voxel-
based morphometry (VBM) was performed using MATLAB7.4.0
(Mathworks, Natick, MA) and SPM2 (Wellcome Department of
Imaging Neuroscience, London, UK). All VBM analyses strictly
adhered to the optimized VBM protocol as described by Good et al
(2001) [25]. All structural images were examined for artifacts and
then reoriented to a center point located on the anterior
commissure. A customized anatomical template was created from
the reoriented structural MRI images of all subjects. Template
creation included spatial normalization of all the images to MNI
space. The customized template was then used in conjunction with
SPM prior images for grey matter, white matter and cerebrospinal
fluid (CSF) as the basis for spatial normalization for all subjects.
Spatially normalized images were then re-sliced with a final voxel
size of 1.561.561.5 mm
3, and were subsequently segmented by
compartmentintogreymatter,whitematter,andCSFimages.After
segmentation, the segmented grey matter images were modulated
by multiplication of the Jacobian determinant of the spatial
normalization function, so as to allow for the estimation of
volumetric differences between groups [25]. Images were then
smoothed using a 12-mm FWHM isotropic Gaussian kernel. All
subsequent statistical analyses were performed on the normalized,
segmented, modulated and smoothed grey matter images.
Group level analysis
Group differences between patients and controls were assessed
using an ANCOVA model as implemented in SPM2, with age, sex
Stress and ACC Volume in MDD
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volume was calculated as the sum of segmented gray, white and
CSF images for each subject.
Volumetric differences between groups were evaluated using
both a whole-brain, and region of interest (ROI) approach.
Whole-brain analyses were conducted using a family-wise error
correction of pFWE,.05 to control for multiple comparisons. A
priori ROI included the anterior cingulate (dorsal and rostral ACC
[BA 24, 32 and 25]) and the hippocampus. These regions were
selected because both have shown evidence of atrophy in MDD
[10–17], and preclinical findings have suggested that both regions
are involved in regulating HPA activity [4,5], and are damaged by
elevated exposure from glucocorticoids resulting from chronic
stress [4,7–9].
ROI for the anterior cingulate and hippocampus were derived
from the Anatomical Automatic Labeling atlas [26] as imple-
mented in the Wake Forest University Pickatlas [27]. Separate
masks were drawn for the rostral and dorsal portions of the
anterior cingulate, consistent with prior findings suggesting that
these sub-regions are differently affected in MDD [19,20]. All
reported clusters were corrected for multiple comparisons using a
family-wise error correction of pFWE,.05.
Correlations between Volume, Cortisol and Early Life
Stress
Once statistically significant clusters were identified, estimates of
grey matter volume from each cluster were extracted from SPM
and entered into SPSS (SPSS for Windows, Rel. 15.0. 2006.
Chicago: SPSS Inc.) for further analysis. All SPSS analyses were
conducted on a Dell Dimension workstation (Dell, Round Rock,
TX), running Windows XP (Microsoft, Redmond, WA). Separate
analyses were used to explore the relationship between GM
volume (within regions identified from group SPM comparisons),
the CTQ combined physical/sexual abuse scale, and total average
cortisol for patients and for controls. Partial correlations were used
to control for the effects of age and sex within each group.
Results
Sample Characteristics
Participants in the study included 19 patients diagnosed with
major depression (female=10) and 19 age, gender and IQ
matched healthy volunteers (female=10). A summary of subject
characteristics is presented in Table 1.
CTQ Results
CTQ data were not available for four of the nineteen control
subjects, who were recruited prior to the inclusion of the CTQ in
the study protocol. Additionally, one control subject was a
statistical outlier (Z-score.3), and was excluded. All patients with
MDD completed the questionnaire. Patients with unipolar
depression had significantly higher scores on all five scales after
correcting for multiple comparisons (Table 1).
Salivary Cortisol Results
Due to insufficient saliva concentrations, accurate cortisol
estimates were unavailable for three control subjects and three
patients. Additionally, one of the control subjects was an outlier
and was excluded from subsequent analysis. Using a one-sample t-
test, it was found that average cortisol levels (the sum of all samples
divided by seven) for the patient group were elevated when
compared to the control group (t29=21.76, p=.045). However,
differences in cortisol secretion between the patient and control
groups were greatest for average morning cortisol (t29=22.32,
p=.014) (Table 1) (Figure 1).
Voxel-Based Morphometry Results – Whole Brain Analysis
There were no significant differences between patients and
controls using a whole brain analysis, correcting for multiple
comparisons at an alpha set to pFWE,.05.
Voxel-Based Morphometry Results – ROI Analysis
ROI analysis of volumetric differences between patients and
controls revealed an area of decreased volume in the MDD group
in the right rostral ACC, BA 32; [x=17 y=44 z=1] (t33=3.86,
pFWE=.041). A second cluster of decreased volume in the MDD
group appeared in the left rostral ACC, BA 24 [x=29y = 3 8
z=0]. This cluster was only marginally significant after correcting
for multiple comparisons (t33=3.54, pFWE=.083) (Figure 2). No
differences between patients and controls were found for the
hippocampus at uncorrected thresholds of either p=.001, or
p=.01.
Correlations between Volume, Cortisol and Early Life
Stress
Estimates of grey matter volume were extracted from all voxels
that survived an uncorrected threshold of p=.01 of the right
rACC cluster. Within the patient group, individual differences in
rACC volume showed a significant inverse correlation using an
inverse curve fit with the combined CTQ sexual and physical
abuse scale (r=2.62, p=.004). This correlation remained
significant after controlling for age (r=2.56, p=.015) and sex
(r=2.68, p=.002). Average salivary cortisol levels were also
inversely correlated with volume in the rACC (r=2.69, p=.003).
Table 1. Demographic Data, CTQ Scores and Salivary Cortisol.
Variable MDD
Healthy
Controls
n Mean SD n Mean SD
Number of female participants 10 10
Age 19 35.2 10.5 19 30.3 8.6
Estimated IQ (Shipley) 19 105.6 7.8 19 108.4 9.9
Hamilton Rating Scale of Depression** 19 21.5 4.1 19 0.84 1.3
Number of previous episodes 19 2.6 0.9 0
Average duration of illness (years) 19 12.9 13.7 0
Past alcohol abuse 2 0
Co-morbid anxiety disorder 7 0
Past anxiety disorder 3 1
{CTQ Emotional Abuse Scale** 19 11.7 6.1 14 5.6 0.7
CTQ Physical Abuse Scale** 19 10.2 4.5 14 5.4 0.7
CTQ Sexual Abuse Scale** 19 10.0 6.9 14 5.0 0
CTQ Emotional Neglect** 19 12.3 4.2 14 6.8 1.9
CTQ Physical Neglect** 19 8.6 4.0 14 5.1 0.36
CTQ Physical and Sexual Abuse Scale** 19 10.1 5.4 14 5.2 0.32
{Salivary Cortisol (morning samples)* 16 10.9 3.5 15 8.2 2.9
Salivary Cortisol (all samples)* 16 7.6 2.0 15 6.3 1.9
*p,.05.
**p,.01.
{outliers and missing data have been excluded.
doi:10.1371/journal.pone.0004887.t001
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(r=2.57, p=.028) and sex (r=2.72, p=.002). Among the
control group, there were no significant correlations between
rACC and the CTQ subscales or cortisol (Table 2) (Figure 3).
Discussion
The present study found that individuals with MDD demon-
strated a volumetric decrease in the right rACC (BA 32) as
compared to controls. This finding is supported in part by previous
studies, which showed that grey matter volume within other sub-
regions of the ACC is reduced in individuals with MDD
[14,16,17]. Notably, our findings demonstrate linkages between
decreased rACC volume in the disorder and both salivary cortisol
and early childhood maltreatment. These data extend findings
from preclinical studies suggesting that observed volumetric
decreases in the ACC may be a consequence of prolonged
exposure to glucocorticoids resulting from chronic stress [7,8].
Localization of the decrease in anterior cingulate volume to the
rostral subdivision is particularly relevant, as this region has been
strongly implicated in the pathophysiology of depression in
previous studies [19,21,28–33]. Additionally, several fMRI studies
using working memory and attention tasks have reported that
individuals with current or remitted MDD exhibit increased rACC
activity in order to match the same level of performance as control
subjects [31–33]. This suggests that the rACC may be less efficient
Figure 1. Time course of salivary cortisol (ng/ml) for patients and controls.
doi:10.1371/journal.pone.0004887.g001
Figure 2. Differences in volume of rACC among controls and patients with MDD. Brain image is masked at an uncorrected threshold at
p,.01.
doi:10.1371/journal.pone.0004887.g002
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result from altered ACC morphology. Consistent with this
interpretation is a recent animal study that found reduced working
memory performance and decreased connectivity between the
hippocampus and ACC following exposure to chronic stress,
which was accompanied by atrophy in laminas I and II of the
ACC [34].
Prior reports of decreased cingulate volume have emphasized
changes in the left hemisphere (14, 17), although some reports
have suggested decreased cingulate volume bilaterally [35,16].
Additionally, a recent meta-analysis of volumetric changes in
depression demonstrated that both right and left anterior cingulate
volumes are reduced in the disorder [36]. In our study, although
we emphasize the volumetric decrease in right anterior cingulate,
which remained significant after correcting for multiple compar-
isons, a small cluster in the left hemisphere was also marginally
significant.
The observed relationship between reduced rACC volume and
a history of early adverse events is consistent with prior findings
that have revealed a relationship between chronic and repeated
stress and anterior cingulate structure [7,8]. The correlation
between elevated cortisol levels and reduced rACC volume among
depressed individuals is also consistent with results from animal
studies regarding the role of mPFC in HPA axis negative feedback
regulation. It is noteworthy that only the average of all seven
cortisol samples was correlated with rACC volume, while the
average of the morning samples was not. This suggests that
volumetric decreases in the rACC are not specifically linked to
peak cortisol activity; rather, rACC volume appears to be more
closely related to sustained glucocorticoid exposure.
Our findings suggest that chronic stress subsequent to childhood
maltreatment may serve to initiate glucocorticoid-related injury to
the ACC. This damage may impair cortico-limbic circuits
Figure 3. Correlations between volumetric decrease in rACC and average cortisol levels for patients (A) and controls (B) and
correlations between volumetric decrease in rACC and the combined CTQ scales for physical and sexual abuse for patients (C) and
controls (D).
doi:10.1371/journal.pone.0004887.g003
Table 2. Correlations between volume, cortisol and CTQ
scores.
Correlations with
right rACC
cluster n rp
MDD Group
CTQ physical and sexual abuse -
combined{
19 20.62 0.004
Cortisol (all samples){ 16 20.69 0.003
Control Group
CTQ physical and sexual abuse -
combined
14 0.10 0.74
Cortisol (all samples) 15 0.02 0.94
{correlations remained significant after controlling for age and sex.
doi:10.1371/journal.pone.0004887.t002
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diminish its ability to exert negative feedback control over future
HPA activity. Together, these two outcomes may result in poor
regulation of stress, and could play a role in both the initiation of
depression and increased vulnerability to recurrence. A recent
longitudinal study also suggests that decreased volume in ACC in
individuals with depression may result from stress [35]. Further
research will be required to clarify the temporal relationships
between early adverse events, increased HPA activity and
structural integrity of the ACC.
We did not find any group differences in the hippocampus. This
may result from heterogeneity of important clinical variables
within our sample, including the number of episodes, duration of
illness and severity of early life trauma. Prior studies that have
identified hippocampal decreases associated with MDD have often
reported that the extent of hippocampal damage is associated with
the duration of illness [10,12] particularly when it is untreated [11]
(cf Campbell and MacQueen, 2006 for a review [15]). In contrast,
the number of previous episodes in our sample ranged from none
to four or more. Similarly, Vythilingam et al found volumetric
decreases in individuals with both MDD and a history of severe
child abuse, but not MDD alone [13]. In our sample, the severity
of early adverse events varied from none to severe. This
heterogeneity in the severity of early life stress may partially
explain why we failed to observe group differences in hippocampal
volume. Finally, it should be mentioned that voxel-based
morphometry is not the ideal method for investigation of the
hippocampus, as the anatomical complexities of this structure
make it very difficult to accurately segment grey and white matter
tissue classes using this technique.
Limitations
Several limitations in the present study warrant mention. First,
we did not find any significant differences using a whole-brain
analysis after correcting for multiple comparisons, suggesting that
where volumetric differences occurred in our depressed subjects,
the effects sizes were only small to moderate. An additional
limitation is the use of the VBM method, which is susceptible to
normalization and segmentation errors. This issue is compounded
by our relatively small sample size, as VBM is best suited for a
sample size of 25 subjects or more per group. It should also be
noted that this method is particularly susceptible to errors in the
evaluation of hippocampal volume, and manual segmentation
remains the preferred method for this region. Further, patients
with MDD were asked to evaluate their history of traumatic
childhood experiences while they were in the acute phase of
depression, which may have influenced their memory for events.
Our study was limited by its reliance on salivary cortisol as the
only measure of HPA activity, as opposed to other forms of
assessment of HPA function such as the dexamethasone
suppression test or the corticotropin releasing hormone (CRH)
test. Finally, the complete neurobiological mechanisms by which
elevated cortisol precipitates structural damage in the ACC are
likely to involve additional variables that were not evaluated in the
present study.
Conclusion
The present study replicates several previous reports suggesting
the MDD is associated with decreased grey matter volume in the
anterior cingulate. In addition, this study suggests that the extent
of grey matter loss is related to both a history of early adverse
events and circulating cortisol levels. These data further implicate
the rostral cingulate as a key region in the regulation of HPA
activity and the pathophysiology of MDD.
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